StockClub

IVBXF

IVBXFInnovent Biologics, Inc.$ --
Innovent Biologics, Inc.

Innovent Biologics, Inc.

IVBXF

$ -

-

Review earnings summary, surprise history, and upcoming forecasts.

wallet
Earnings Summary
Updated: 06/30/2025FY2025 Q2
Revenue
5,953M CNY
YoY +50.6%
Operating Income
774M CNY
YoY +204.4%
Net Income
834M CNY
YoY +312.5%
EPS
0.51CNY
YoY +312.5%

Revenue

CNY6B
FY2021 Q4CNY4.3B
CNY4.3B
Q4
FY2022 Q2CNY2.2B
CNY2.2B
Q2
FY2022 Q4CNY4.6B
CNY4.6B
Q4
FY2023 Q2CNY2.7B
CNY2.7B
Q2
FY2023 Q4CNY6.2B
CNY6.2B
Q4
FY2024 Q2CNY4B
CNY4B
Q2
FY2024 Q4CNY9.4B
CNY9.4B
Q4
FY2025 Q2CNY6B
CNY6B
Q2
Actual
+CNY2B (+50.6%)

Net Income

CNY834.3M
FY2021 Q4CNY-2.7B
CNY-2.7B
Q4
FY2022 Q2CNY-950.5M
CNY-950.5M
Q2
FY2022 Q4CNY-2.2B
CNY-2.2B
Q4
FY2023 Q2CNY-139.1M
CNY-139.1M
Q2
FY2023 Q4CNY-1B
CNY-1B
Q4
FY2024 Q2CNY-392.6M
CNY-392.6M
Q2
FY2024 Q4CNY-94.6M
CNY-94.6M
Q4
FY2025 Q2CNY834.3M
CNY834.3M
Q2
Actual
+CNY1.2B (+312.5%)

Surprise History

Actual RevenueAnalyst Estimate
FY2019BEAT
Actual:CNY1B
Est:CNY861.4M
FY2019BEAT
CNY1B
FY2020BEAT
Actual:CNY3.8B
Est:CNY3.2B
FY2020BEAT
CNY3.8B
FY2021BEAT
Actual:CNY4.3B
Est:CNY4.1B
FY2021BEAT
CNY4.3B
FY2022MISS
Actual:CNY4.6B
Est:CNY4.6B
FY2022MISS
CNY4.6B
FY2023BEAT
Actual:CNY6.2B
Est:CNY6B
FY2023BEAT
CNY6.2B
FY2024BEAT
Actual:CNY9.4B
Est:CNY8.3B
FY2024BEAT
CNY9.4B

Analyst Estimates